GPER-1 agonist G1 induces vasorelaxation through activation of epidermal growth factor receptor-dependent signalling pathway

17β-Estradiol induces vasorelaxation in a G-protein-coupled receptor 30-independent manner

(2013) Young Mi Seok et al.   NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

G Protein-Coupled Receptor 30 Mediates Estrogen-Induced Proliferation of Primordial Germ Cells Via EGFR/Akt/β-Catenin Signaling Pathway

(2012) Chutian Ge et al.   ENDOCRINOLOGY

c-Src-dependent EGF receptor transactivation contributes to ET-1-induced COX-2 expression in brain microvascular endothelial cells

(2012) Hsi-Lung Hsieh et al.   Journal of Neuroinflammation

Improvement of Vascular Function by Acute and Chronic Treatment with the GPR30 Agonist G1 in Experimental Diabetes Mellitus

(2012) Zi-lin Li et al.   PLoS One

Mechanisms of Estradiol-Induced Insulin Secretion by the G Protein-Coupled Estrogen Receptor GPR30/GPER in Pancreatic β-Cells

(2011) Geetanjali Sharma et al.   ENDOCRINOLOGY

Equol-Stimulated Mitochondrial Reactive Oxygen Species Activate Endothelial Nitric Oxide Synthase and Redox Signaling in Endothelial Cells

(2011) David J. Rowlands et al.   HYPERTENSION

Vasodilation in Response to the GPR30 Agonist G-1 is Not Different From Estradiol in the mRen2.Lewis Female Rat

(2011) Sarah H Lindsey et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

Endothelium-dependent relaxation by G protein-coupled receptor 30 agonists in rat carotid arteries

(2010) Brad R. S. Broughton et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Highly efficient synthesis and characterization of the GPR30-selective agonist G-1 and related tetrahydroquinoline analogs

(2010) Ritwik Burai et al.   ORGANIC & BIOMOLECULAR CHEMISTRY

Endothelial nitric oxide synthase transgenic models of endothelial dysfunction

(2010) Dmitriy N. Atochin et al.   PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY

Genistein enhances relaxation of the spontaneously hypertensive rat aorta by transactivation of epidermal growth factor receptor following binding to membrane estrogen receptors-α and activation of a G protein-coupled, endothelial nitric oxide synthase-dependent pathway

(2010) Amanda H.Y. Lin et al.   PHARMACOLOGICAL RESEARCH

Dilation of Epicardial Coronary Arteries by the G Protein-Coupled Estrogen Receptor Agonists G-1 and ICI 182,780

(2010) Matthias R. Meyer et al.   PHARMACOLOGY

Regulatory Role of G Protein–Coupled Estrogen Receptor for Vascular Function and Obesity

(2009) Elvira Haas et al.   CIRCULATION RESEARCH

Chronic Treatment with the G Protein-Coupled Receptor 30 Agonist G-1 Decreases Blood Pressure in Ovariectomized mRen2.Lewis Rats

(2009) Sarah Hoffmann Lindsey et al.   ENDOCRINOLOGY

In vivo effects of a GPR30 antagonist

(2009) Megan K Dennis et al.   Nature Chemical Biology

GPR30/GPER1: searching for a role in estrogen physiology

(2009) Björn Olde et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Expression Pattern of G Protein-Coupled Receptor 30 in LacZ Reporter Mice

(2008) Jörg Isensee et al.   ENDOCRINOLOGY

Isoflavone Attenuates Vascular Contraction through Inhibition of the RhoA/Rho-Kinase Signaling Pathway

(2008) Y. M. Seok et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

GPR30: a novel therapeutic target in estrogen-related disease

(2008) Eric R. Prossnitz et al.   TRENDS IN PHARMACOLOGICAL SCIENCES